✦ LIBER ✦

A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin

✍ Scribed by Kowalski, Mark; Guindon, Jacinthe; Brazas, Louise; Moore, Celine; Entwistle, Joycelyn; Cizeau, Jeannick; Jewett, Michael A.S.; MacDonald, Glen C.

Book ID: 119308253
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 397 KB
Volume: 188
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.07.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on “A phase II study of oport

Commentary on “A phase II study of oportuzumab monatox: An immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin.” Kowalski M, Guindon J, Brazas L, Moore C, Entwistle J, Cizeau J, Jewett MA, MacDonald GC

✍ See, William A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 119 KB

A PHASE II STUDY TO EVALUATE THE EFFICAC

A PHASE II STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF INTRAVESICAL VICINIUM™ IN PATIENTS WITH CARCINOMA IN SITU (CIS) PREVIOUSLY TREATED WITH BACILLE CALMETTE-GUÉRIN (BCG): PRELIMINARY RESULTS

✍ Kowalski, Mark; Jones, Nicola; Jewett, Michael AS; Cuthbert, Wendy; Glover, Nick 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 130 KB

A phase II clinical trial of oral bropir

A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: A Southwest Oncology Group Study

✍ Michael F. Sarosdy; Catherine M. Tangen; Geoffrey R. Weiss; Blake R. Nestok; Mit 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Phase II study of intravesical therapy w

Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): A trial of the Eastern Cooperative Oncology Group

✍ Jeffrey M. Ignatoff; Yu-Hui Chen; Richard Evan Greenberg; Julio M. Pow-Sang; Edw 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Re: Richard J. Sylvester, Maurizio A. Br

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

✍ Tommaso Cai; Lorenzo Giuseppe Luciani; Gianni Malossini 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Long-term results of maintenance treatme

Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette–Guérin instillation therapy of patients with carcinoma in situ of the bladder: A subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up

✍ Järvinen, Riikka; Kaasinen, Eero; Rintala, Erkki; Group, The Finnbladder 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 401 KB